Art

J-GLOBAL ID：202002266393338719   Reference number：20A1164274

Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line

日本における第一選択でのチロシンキナーゼ阻害剤に対する抵抗性や不耐性を有する慢性期の慢性骨髄性白血病の治療転帰:New TARGET試験第二選択の結果

Author (21)： Sakurai Masatoshi (Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Okamoto Shinichiro (Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan) ,  Matsumura Itaru (Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan) ,  Murakami Satsuki (Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan) ,  Takizawa Makiko (Department of Hematology, Gunma University Hospital, Gunma, Japan) ,  Waki Masato (Department of Hematology, Kagawa Prefectural Central Hospital, Kagawa, Japan) ,  Hirano Daiki (Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan) ,  Watanabe-Nakaseko Reiko (Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan) ,  Kobayashi Naoki (Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan) ,  Iino Masaki (Department of Hematology and Hematopoietic Stem Cell Transplantation, Yamanashi Prefectural Central Hospital, Yamanashi, Japan) ,  Mitsui Hideki (Department of Hematology, Otemae Hospital, Osaka, Japan) ,  Ishikawa Yuichi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Takahashi Naoto (Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan) ,  Kawaguchi Tatsuya (Department of Medical Technology, Kumamoto Health Science University, Kumamoto, Japan) ,  Suzuki Ritsuro (Department of Oncology and Hematology, Shimane University Hospital, Izumo, Japan) ,  Yamamoto Kazuhito (Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan) ,  Kizaki Masahiro (Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan) ,  Ohnishi Kazunori (Tokai-Hokuriku Block Blood Center, Seto, Japan) ,  Naoe Tomoki (Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan) ,  Akashi Koichi (Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan) ,  the New TARGET investigators
Material： International Journal of Hematology  (Int J Hematol)
Volume： 111  Issue： 6  Page： 812-825  Publication year： Jun. 2020 
JST Material Number： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *chronic myeloid leukemia ,...
Semi thesaurus term： BCR-ABL gene ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1164274&from=J-GLOBAL&jstjournalNo=F0888A") }}

Author keywords (5)： Chronic myeloid leukemia ,  Resistance or intolerance ,  Tyrosine kinase inhibitors ,  Observational study ,  Japan

JST classification (3)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Imatinib ,  Dasatinib ,  Nilotinib

Terms in the title (9)： 日本 ,  チロシンキナーゼ阻害剤 ,  抵抗性 ,  耐性 ,  慢性期 ,  慢性骨髄性白血病 ,  治療 ,  転帰 ,  試験